Bridgewater Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
CCM
EAM
EC
CCM
Bridgewater Associates's EVH Position: Q1 2025 in Review
Bridgewater Associates sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 21,118 shares — an estimated $238K sold.
Bridgewater Associates first reported a position in EVH in Q2 2021 and held it in 15 quarters. The position peaked at $8.4M in Q3 2022. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.
- Bridgewater Associates reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
- Bridgewater Associates sold 21,118 Evolent Health shares in Q1 2025, an estimated $238K.
- Bridgewater Associates first reported a position in Evolent Health in Q2 2021 and held it in 15 quarters.
- Bridgewater Associates's Evolent Health position peaked at $8.4M in Q3 2022.
- 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.
Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.